Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease

類似資料

• Soluble TWEAK and PTX3 in Nondialysis CKD Patients: Impact on Endothelial Dysfunction and Cardiovascular Outcomes
  著者:: Yilmaz, Mahmut Ilker, 等
  出版事項: (2011)
• Combined Therapy with Renin-Angiotensin System and Calcium Channel Blockers in Type 2 Diabetic Hypertensive Patients with Proteinuria: Effects on Soluble TWEAK, PTX3, and Flow-Mediated Dilation
  著者:: Yilmaz, Mahmut Ilker, 等
  出版事項: (2010)
• Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD
  著者:: Carrero, Juan Jesús, 等
  出版事項: (2012)
• Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
  著者:: Carrero, Juan J., 等
  出版事項: (2009)
• Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney Disease
  著者:: Kanbay, Mehmet, 等
  出版事項: (2011)